secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2023-01-03T23:59:59+00:00
Accession:  0000950170-23-000055
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Heart Test Laboratories board changes: Kanouff resigns, Wells appointed
-----------------------------------------------------------------------

- Director Patrick Kanouff voluntarily resigned from board and all committees effective Dec 27, 2022.
- David R. Wells appointed to board effective Dec 28, 2022; serves on Audit, Compensation, and Nominating committees.
- Wells is independent; background includes CFO at ENDRA Life Sciences and GHS Investments, founder of Atlas Bookkeeping.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000095017023000055/0000950170-23-000055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000095017023000055/hscs-20221227.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-000055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer